| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 07/26/2005 | US6921829 Organic compound in liquid or dissolved form is mixed with formylation reagent in liquid or dissolved form in microreactor; efficiency, simplification |
| 07/26/2005 | US6921805 Neo-tryptophan-containing neurotension polypeptide analogs having enhanced biological effects as compared to NT itself; antinociception/anorexogenic agents; induction of thirst, hypothermia, weight loss, appetite; psychological disorders |
| 07/26/2005 | US6921772 Methods and compositions for the treatment of chronic lymphocytic leukemia |
| 07/26/2005 | CA2253948C Carboline derivatives |
| 07/26/2005 | CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives |
| 07/26/2005 | CA2190202C Cyclopentenecarboxamide derivative, method for preparing the same and bicycloamide derivative used therein |
| 07/26/2005 | CA2152902C Selective ligands of receptors 5-ht1d-5ht1b derived from indole-piperazine useful as medicaments |
| 07/26/2005 | CA2152630C Enantiomers of carbazole derivatives as 5-ht1-like agonists |
| 07/21/2005 | WO2005066135A2 Pyrrole and pyrazole daao inhibitors |
| 07/21/2005 | WO2005066126A1 Cb1 modulator compounds |
| 07/21/2005 | WO2005066125A1 Cis-alkoxyspiro-substituted tetramic acid derivatives |
| 07/21/2005 | WO2005066121A2 Multifunctional amine capture agents |
| 07/21/2005 | WO2005065779A1 Calcitonin gene related peptide receptor antagonists |
| 07/21/2005 | WO2005042497A3 Benzimidazoles useful as modulators of ion channels |
| 07/21/2005 | WO2005040113A8 Processes for the preparation of a polymorph of fluvastatin sodium |
| 07/21/2005 | WO2005018561A3 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 07/21/2005 | WO2005013914A3 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 07/21/2005 | WO2004087051A3 Ophthalmic compositions for treating ocular hypertension |
| 07/21/2005 | WO2004043920A8 Polymorphs of bicifadine hydrochloride |
| 07/21/2005 | US20050159613 Cytosolic phospholipase A2 (cPLA2); chemical intermediates such as N-But-3-ynyl-1-(3,4-dichlorophenyl)methanesulfonamide; reacting by a substituted benzylsulfonyl chloride with an alkynylamine; end drugs are 2-sulfamido(alkyl) indoles |
| 07/21/2005 | US20050159605 For treatment of Parkinson's disease or cardiovascular disorders |
| 07/21/2005 | US20050159604 Asymmetric hydrogenation of alpha-amino carbonyl compounds |
| 07/21/2005 | US20050159487 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 07/21/2005 | US20050159480 Preparation of statins by reacting (trisubstituted phosphoranylidenecarbonyl)acetates with benzaldehydes, reduction with diamino-group 8 metal coordinates, condensation with 1-hydroxy-1-alkoxyethylenes, hydrolysis, and optionally converting the carboxy acid product into a salt or a lactone |
| 07/21/2005 | US20050159474 Chemical compounds |
| 07/21/2005 | US20050159473 3-Substituted oxindole beta3 agonists |
| 07/21/2005 | US20050159472 Chemical compounds |
| 07/21/2005 | US20050159463 5-methoxy-3-(2-(2-furamido) ethyl)indole; related to melatonin, but pharmacologicaly and pharmacokineticy different; longer duration, selective localization and greater efficacy |
| 07/21/2005 | US20050159452 Nociceptin analogs |
| 07/21/2005 | US20050159451 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 07/21/2005 | US20050159415 Agents for preventing or ameliorating insulin resistance and /or obesity |
| 07/21/2005 | CA2552737A1 Cis-alkoxyspiro-substituted tetramic acid derivatives |
| 07/21/2005 | CA2551952A1 Pyrrole and pyrazole daao inhibitors |
| 07/21/2005 | CA2550869A1 Process for the preparation of phthalocyanines |
| 07/21/2005 | CA2549396A1 Cb1 modulator compounds |
| 07/21/2005 | CA2549330A1 Calcitonin gene related peptide receptor antagonists |
| 07/20/2005 | EP1554361A1 Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions |
| 07/20/2005 | EP1554271A1 Substituted indoles and their use as hcv inhibitors |
| 07/20/2005 | EP1554262A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 07/20/2005 | EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 07/20/2005 | EP1554244A1 1-heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 07/20/2005 | EP1554243A1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases |
| 07/20/2005 | EP1554239A2 Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists |
| 07/20/2005 | EP1554235A2 Process for synthesizing l-y-methylene glutamic acid and analogs |
| 07/20/2005 | EP1553937A2 Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods |
| 07/20/2005 | EP1189583B1 Indole derivatives |
| 07/20/2005 | EP1185493B1 Quinones for treatment of diseases |
| 07/20/2005 | EP1146867B1 Antibacterial hydroxamic acid derivatives |
| 07/20/2005 | EP1056717B1 Arylphenyl-substituted cyclic keto-enols |
| 07/20/2005 | EP0828851B1 Tripeptidylpeptidase inhibitors |
| 07/20/2005 | EP0784430B1 Method for reducing unwanted cellular adhesions |
| 07/20/2005 | CN1643108A Phosphorescent compositions and organic light emitting devices containing them |
| 07/20/2005 | CN1642942A Method for manufacture of sertindole |
| 07/20/2005 | CN1642938A New compounds |
| 07/20/2005 | CN1642928A Process for the preparation of morpholine derivatives and intermediates therefore |
| 07/20/2005 | CN1642911A Phthalimido derivatives as inhibitors of monoamine oxidase B |
| 07/20/2005 | CN1642910A Synthesis of indole thiazole compounds as ligands for the AH receptor |
| 07/20/2005 | CN1642752A Optical recording media and dipyrromethene-metal chelate compounds |
| 07/20/2005 | CN1642555A Statin therapy for enhancing cognitive maintenance |
| 07/20/2005 | CN1641488A Electrophotographic organophotoreceptors with novel change transport compounds |
| 07/20/2005 | CN1211365C Novel salt of perindopril and pharmacetuical composition contg. same |
| 07/20/2005 | CN1211364C Novel salt compound of indole stryene and application in high density recording media |
| 07/20/2005 | CN1211363C Novel salt compound of benzol indole styrene and application in high density recording media |
| 07/19/2005 | US6919445 Detecting with a multicolor fluorescent dyes, for automated 4-DNA sequencing systems, identifying the classes of the polynucleotides |
| 07/19/2005 | US6919418 Approach to reduce cyclics formation in 3-CIPA based polyetherimide polymers |
| 07/19/2005 | US6919375 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 07/19/2005 | US6919355 Amide derivatives as NMDA receptor antagonists |
| 07/19/2005 | US6919354 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 07/19/2005 | US6919344 Heterocyclic amines such as N-(Pyridin-4-yl)-(1-(4-fluoro-benzyl)indol-3-yl)glyoxylamide, used for prophylaxis of skin disorders, rheumatic diseases or arthritis |
| 07/14/2005 | WO2005063690A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 07/14/2005 | WO2005063689A1 Benzamide derivative |
| 07/14/2005 | WO2005063678A1 Process for producing phenylacetic acid derivative |
| 07/14/2005 | WO2005063239A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 07/14/2005 | WO2005062992A2 Substituted melatonin derivatives, process for their preparation, and methods of use |
| 07/14/2005 | WO2005040073A3 Solid phase synthesis of 3-aryl-2- indolylcarboxylic acids |
| 07/14/2005 | WO2005035514A3 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 07/14/2005 | WO2004108085A3 Methods for the protection of memory and cognition |
| 07/14/2005 | US20050154230 Urea derivatives |
| 07/14/2005 | US20050154202 Substituted aryl amides |
| 07/14/2005 | US20050154062 Substituted chiral allosteric hemoglobin modifiers |
| 07/14/2005 | US20050154056 Inhibitors of HCV NS5B polymerase |
| 07/14/2005 | US20050154044 Substituted tetrahydrocarbazole and cyclopentanoindole derivatives |
| 07/14/2005 | US20050154023 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease |
| 07/14/2005 | US20050153996 Compounds that modulate ppar activity and methods for their preparation |
| 07/14/2005 | US20050153987 Compounds |
| 07/14/2005 | US20050153980 Substituted indoles |
| 07/14/2005 | US20050153942 Heterocyclic inhibitors of MEK and methods of use thereof |
| 07/14/2005 | US20050153900 Novel inhibitors of hepatitis C virus NS3/NS4a serine protease |
| 07/14/2005 | US20050153244 Sulfonate derivatives and the use thereof as latent acids |
| 07/14/2005 | CA2645396A1 Process for preparation of statins with high syn to anti ratio |
| 07/14/2005 | CA2551117A1 Substituted melatonin derivatives, process for their preparation, and methods of use |
| 07/14/2005 | CA2550649A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 07/13/2005 | EP1553457A2 Electrophotographic organophotoreceptors with change transport compounds |
| 07/13/2005 | EP1553179A1 Mouse-origin proteins forming domain or use thereof |
| 07/13/2005 | EP1553097A1 Quinazoline derivatives as angiogenesis inhibitors and intermediates therefore |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1553074A1 Fused benzene derivative and use |
| 07/13/2005 | EP1551830A2 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibators |
| 07/13/2005 | EP1551810A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 07/13/2005 | EP1551807A1 Improved reagents for n-amination |